Clarius Group LLC’s Twist Bioscience TWST Stock Holding History

Clarius Group LLC’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$1.57M	Hold	49,635	–	–	0.09%	89
2025 Q3	$1.4M	Hold	49,635	–	–	0.08%	100
2025 Q2	$1.83M	Hold	49,635	–	–	0.11%	87
2025 Q1	$1.95M	Hold	49,635	–	–	0.12%	75
2024 Q4	$2.31M	Hold	49,635	–	–	0.16%	61
2024 Q3	$2.24M	Hold	49,635	–	–	0.16%	62
2024 Q2	$2.45M	Hold	49,635	–	–	0.17%	58
2024 Q1	$1.7M	Hold	49,635	–	–	0.12%	81
2023 Q4	$1.83M	Hold	49,635	–	–	0.15%	77
2023 Q3	$1.01M	Hold	49,635	–	–	0.1%	112
2023 Q2	$1.02M	Hold	49,635	–	–	0.08%	140
2023 Q1	$748K	Sell	49,635 -1,176	-2%	-$26K	0.06%	174
2022 Q4	$1.21M	Buy	50,811 +1,176	+2%	+$34.1K	0.11%	114
2022 Q3	$1.75M	Hold	49,635	–	–	0.17%	71
2022 Q2	$1.74M	Buy	+49,635	New	+$1.76M	0.17%	75

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Clarius Group LLC's TWST Position: Q4 2025 in Review

Clarius Group LLC held its Twist Bioscience (TWST) position steady in Q4 2025 at 49,635 shares worth $1.57M. The position accounts for 0.09% of the portfolio, ranked #89.

Clarius Group LLC first reported a position in TWST in Q2 2022 and has held it in 15 quarters since. The position peaked at $2.45M in Q2 2024. 244 funds tracked by Wall St. Rank hold TWST as of Q4 2025.

Clarius Group LLC held 49,635 shares of Twist Bioscience worth $1.57M as of Q4 2025.
Clarius Group LLC left its Twist Bioscience share count unchanged in Q4 2025.
Twist Bioscience made up 0.09% of Clarius Group LLC's portfolio in Q4 2025, its #89 holding.
Clarius Group LLC first reported a position in Twist Bioscience in Q2 2022 and has held it in 15 quarters since.
Clarius Group LLC's Twist Bioscience position peaked at $2.45M in Q2 2024.
244 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2025.

Based on Clarius Group LLC's 13F filing for Q4 2025, filed 14 Jan 2026.